These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
323 related articles for article (PubMed ID: 29871201)
1. [Expression and significance of serum E-cadherin in patients with papillary thyroid carcinoma]. Sun L; Wang DM; Zhang WJ; Zhang J; Wu JF Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jan; 31(2):123-126. PubMed ID: 29871201 [No Abstract] [Full Text] [Related]
2. Disparity expression of gammaH2AX in papillary thyroid cancer and nodular goiter. Hu S; Zhang G; Xu J; Zhu X; Lu X; Jiang L; Wang Q; Hou X; Cao J; Ge M Clin Lab; 2014; 60(12):2031-7. PubMed ID: 25651738 [TBL] [Abstract][Full Text] [Related]
3. [Expression of microRNA-221 and IL-17 in papillary thyroid carcinoma and correlation with clinicopathologic features]. Jiang XL; Zhang H; Chen YL; Peng L Zhonghua Bing Li Xue Za Zhi; 2017 Mar; 46(3):160-165. PubMed ID: 28297755 [No Abstract] [Full Text] [Related]
4. Different Expression of Erythrocyte Sedimentation Rate and C-reactive Protein in Papillary Thyroid Carcinoma and Nodular Goiter. Hou X; Jiang L; Chen C; Zhu X; Ge M Clin Lab; 2015; 61(7):793-9. PubMed ID: 26299079 [TBL] [Abstract][Full Text] [Related]
5. [The expression and clinical significance of EphA2 and E-cadherin in papillary thyroid carcinoma]. Liu Y; Miao Y; Li X Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Jun; 29(11):1020-3. PubMed ID: 26536708 [TBL] [Abstract][Full Text] [Related]
6. Correlation between serum lead and thyroid diseases: papillary thyroid carcinoma, nodular goiter, and thyroid adenoma. Li H; Li X; Liu J; Jin L; Yang F; Wang J; Wang O; Gao Y Int J Environ Health Res; 2017 Oct; 27(5):409-419. PubMed ID: 28891673 [TBL] [Abstract][Full Text] [Related]
7. Correlations of HOTAIR expression with pathological stage, CT characteristics and prognosis of patients with papillary thyroid carcinoma. Chen X; Jin J; Zheng L; Sheng Y; Sun J J BUON; 2021; 26(1):259-265. PubMed ID: 33721460 [TBL] [Abstract][Full Text] [Related]
8. Serum levels of sex hormones and expression of their receptors in thyroid tissue in female patients with various types of thyroid neoplasms. Liu J; Chen G; Meng XY; Liu ZH; Dong S Pathol Res Pract; 2014 Dec; 210(12):830-5. PubMed ID: 25305147 [TBL] [Abstract][Full Text] [Related]
9. Hashimoto's thyroiditis, nodular goiter or follicular adenoma combined with papillary thyroid carcinoma play protective role in patients. Ma H; Li L; Li K; Wang T; Zhang Y; Zhang C; Xu Y; Wu X; Yu J; Wang H; Xiang B; Zhang R; Wang W Neoplasma; 2018 Mar; 65(3):436-440. PubMed ID: 29788738 [TBL] [Abstract][Full Text] [Related]
10. [The study of the correlation of papillary thyroid carcinoma's invasion toward Ezrin and E-cadherin]. Liu C; Chen X; Gao Z; Liu Z; Tao X Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Sep; 26(17):789-91, 795. PubMed ID: 23214316 [TBL] [Abstract][Full Text] [Related]
11. Circulating levels of PTEN and KLLN in papillary thyroid carcinoma: can they be considered as novel diagnostic biomarkers? Razavi SA; Modarressi MH; Yaghmaei P; Tavangar SM; Hedayati M Endocrine; 2017 Sep; 57(3):428-435. PubMed ID: 28755140 [TBL] [Abstract][Full Text] [Related]
12. Expressions of miRNAs in papillary thyroid carcinoma and their associations with the clinical characteristics of PTC. Hu J; Li C; Liu C; Zhao S; Wang Y; Fu Z Cancer Biomark; 2017; 18(1):87-94. PubMed ID: 28085013 [TBL] [Abstract][Full Text] [Related]
13. [Relationship between activated STAT3 protein and epithelial-mesenchymal transition in papillary thyroid carcinoma]. Zhang Z; Bai Y; Li P; Zhao J; Wang Y; Sun L; Tang J Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Nov; 27(22):1265-8. PubMed ID: 24616987 [TBL] [Abstract][Full Text] [Related]
14. The expression and role of serum response factor in papillary carcinoma of the thyroid. Kim HJ; Kim KR; Park HS; Jang KY; Chung MJ; Shong M; Moon WS Int J Oncol; 2009 Jul; 35(1):49-55. PubMed ID: 19513551 [TBL] [Abstract][Full Text] [Related]
15. T cell exhaustion is associated with the risk of papillary thyroid carcinoma and can be a predictive and sensitive biomarker for diagnosis. Zhu C; Dai Y; Zhang H; Ruan Y; Zhou Y; Dai Y; Fan L; Jia T; Lu H; Chen Q Diagn Pathol; 2021 Aug; 16(1):84. PubMed ID: 34465342 [TBL] [Abstract][Full Text] [Related]
16. [Study of the correlation of papillary thyroid carcinoma's invasion with Ezrin, Moesin and E-Cadherin]. Tao XF; Liu C; Bai Y; Chen X Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Sep; 46(9):761-3. PubMed ID: 22177047 [TBL] [Abstract][Full Text] [Related]
17. L-thyroxine-treated patients with nodular goiter have lower serum TSH and lower frequency of papillary thyroid cancer: results of a cross-sectional study on 27 914 patients. Fiore E; Rago T; Provenzale MA; Scutari M; Ugolini C; Basolo F; Di Coscio G; Miccoli P; Grasso L; Pinchera A; Vitti P Endocr Relat Cancer; 2010 Mar; 17(1):231-9. PubMed ID: 20167722 [TBL] [Abstract][Full Text] [Related]
18. RET/PTC Rearrangements Are Associated with Elevated Postoperative TSH Levels and Multifocal Lesions in Papillary Thyroid Cancer without Concomitant Thyroid Benign Disease. Su X; He C; Ma J; Tang T; Zhang X; Ye Z; Long Y; Shao Q; Shao J; Yang A PLoS One; 2016; 11(11):e0165596. PubMed ID: 27802347 [TBL] [Abstract][Full Text] [Related]
19. [Expression of mucin-l and beta-catenin in papillary thyroid carcinoma and the clinical significance thereof]. He F; Li H; Li WS; Dong XH Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(6):393-6. PubMed ID: 19567117 [TBL] [Abstract][Full Text] [Related]
20. [ Zhang X; Su X; Chen WC; Li Y; Yang ZY; Deng WZ; Deng TC; Yang AK Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jun; 52(6):435-439. PubMed ID: 28635216 [No Abstract] [Full Text] [Related] [Next] [New Search]